Len Farol

640 total citations
12 papers, 389 citations indexed

About

Len Farol is a scholar working on Pathology and Forensic Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Len Farol has authored 12 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 5 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Len Farol's work include Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Cytomegalovirus and herpesvirus research (3 papers). Len Farol is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (4 papers) and Cytomegalovirus and herpesvirus research (3 papers). Len Farol collaborates with scholars based in United States. Len Farol's co-authors include Kenneth B. Hymes, Stephen J. Forman, Auayporn Nademanee, Sandra H. Thomas, Robert Chen, Joycelynne Palmer, Ni‐Chun Tsai, Ajay K. Gopal, Leslie Popplewell and Jeff Longmate and has published in prestigious journals such as Blood, Annals of Internal Medicine and Biology of Blood and Marrow Transplantation.

In The Last Decade

Len Farol

11 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Len Farol United States 8 165 158 106 93 71 12 389
Elizabeth Brém United States 10 93 0.6× 112 0.7× 37 0.3× 86 0.9× 21 0.3× 35 270
Keith Fay Australia 10 97 0.6× 105 0.7× 86 0.8× 94 1.0× 19 0.3× 30 354
J Palou Spain 13 84 0.5× 133 0.8× 132 1.2× 117 1.3× 17 0.2× 32 456
Dawn Hayward United States 5 237 1.4× 342 2.2× 104 1.0× 136 1.5× 130 1.8× 6 533
G Prentice Australia 7 69 0.4× 103 0.7× 70 0.7× 71 0.8× 19 0.3× 13 387
Janet Li United States 9 41 0.2× 203 1.3× 271 2.6× 100 1.1× 103 1.5× 20 478
Nobuya Hiraoka Japan 9 72 0.4× 74 0.5× 32 0.3× 78 0.8× 15 0.2× 22 254
Pierre Sohier France 12 59 0.4× 80 0.5× 90 0.8× 174 1.9× 57 0.8× 39 512
Juying Wei China 12 75 0.5× 212 1.3× 76 0.7× 105 1.1× 19 0.3× 44 380
Karmela K Chan United States 10 35 0.2× 302 1.9× 41 0.4× 77 0.8× 13 0.2× 22 439

Countries citing papers authored by Len Farol

Since Specialization
Citations

This map shows the geographic impact of Len Farol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Len Farol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Len Farol more than expected).

Fields of papers citing papers by Len Farol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Len Farol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Len Farol. The network helps show where Len Farol may publish in the future.

Co-authorship network of co-authors of Len Farol

This figure shows the co-authorship network connecting the top 25 collaborators of Len Farol. A scholar is included among the top collaborators of Len Farol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Len Farol. Len Farol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Aldoss, Ibrahim, Corinna La Rosa, Lindsey R. Baden, et al.. (2020). Poxvirus Vectored Cytomegalovirus Vaccine to Prevent Cytomegalovirus Viremia in Transplant Recipients. Annals of Internal Medicine. 172(5). 306–316. 47 indexed citations
2.
Herrera, Alex F., Lu Chen, Yago Nieto, et al.. (2020). Consolidation with Nivolumab and Brentuximab Vedotin after Autologous Hematopoietic Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma. Blood. 136(Supplement 1). 19–20. 14 indexed citations
3.
4.
Chen, Robert, Joycelynne Palmer, Ni‐Chun Tsai, et al.. (2014). Brentuximab Vedotin Is Associated with Improved Progression-Free Survival after Allogeneic Transplantation for Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 20(11). 1864–1868. 45 indexed citations
5.
6.
Htut, Myo, Ghislaine Gallez‐Hawkins, Joycelynne Palmer, et al.. (2013). NK Cell Recovery and Costimulatory Molecule Profiles After Autologous Hematopoietic Cell Transplantation (HCT) in Multiple Myeloma (MM) Patients. Biology of Blood and Marrow Transplantation. 19(2). S203–S204. 1 indexed citations
7.
Chen, Robert, Joycelynne Palmer, Sandra H. Thomas, et al.. (2012). Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma. Blood. 119(26). 6379–6381. 95 indexed citations
8.
Sahebi, Firoozeh, Paul Frankel, Len Farol, et al.. (2011). Sequential Bortezomib, Dexamethasone, and Thalidomide Maintenance Therapy after Single Autologous Peripheral Stem Cell Transplantation in Patients with Multiple Myeloma. Biology of Blood and Marrow Transplantation. 18(3). 486–492. 12 indexed citations
9.
Chen, Robert W., Stephen J. Forman, Joycelynne Palmer, et al.. (2011). Brentuximab Vedotin (SGN-35) Enables Successful Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma. Blood. 118(21). 664–664. 7 indexed citations
10.
11.
Cho, Hearn Jay, Len Farol, Wayne R. Austin, et al.. (2005). CT7 (MAGE-C1)-Specific Cellular Immune Responses in the Bone Marrow Microenvironment of Multiple Myeloma Patients.. Blood. 106(11). 356–356. 1 indexed citations
12.
Farol, Len & Kenneth B. Hymes. (2004). Bexarotene: a clinical review. Expert Review of Anticancer Therapy. 4(2). 180–188. 109 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Brém Breakdown of academic impact, for papers by Keith Fay Breakdown of academic impact, for papers by J Palou Breakdown of academic impact, for papers by Dawn Hayward Breakdown of academic impact, for papers by G Prentice Breakdown of academic impact, for papers by Janet Li Breakdown of academic impact, for papers by Nobuya Hiraoka Breakdown of academic impact, for papers by Pierre Sohier Breakdown of academic impact, for papers by Juying Wei Breakdown of academic impact, for papers by Karmela K Chan
Rankless by CCL
2026